LIM Domain Binding 3 Protein 抗体 (N-Term)
Quick Overview for LIM Domain Binding 3 Protein 抗体 (N-Term) (ABIN6242422)
抗原
See all LIM Domain Binding 3 Protein (LDB3) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 101-134, N-Term
- 
                                            纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 
                                            免疫原
- This LDB3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 101-134 amino acids from the N-terminal region of human LDB3.
- 
                                            亚型
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB: 1:1000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - LIM Domain Binding 3 Protein (LDB3) (LIM Domain Binding 3 (LDB3))
- 
                                            别名
- LDB3
- 
                                            背景
- May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton.
- 
                                            分子量
- 77135
- 
                                            UniProt
- O75112
 抗原
- 
                    
 
                                     
                                     
                                    